Skip to main content

FDA Delays Decision Over Juul's Vaping Products

FDA Delays Decision Over Juul's Vaping Products

FDA Delays Decision Over Juul's Vaping Products

Introduction

The officials of the Food & Drug Administration (FDA) of the United States delayed the decision of Juul vaping products that would decide the fate of the product in the U.S. market.

FDA banned thousands of electronic cigarettes and related products to prevent underage smoking, but the agency did not rule on Juul, which is the most popular brand among adults and teens. The agency has been repeatedly pressurized by parents, politicians and anti-tobacco advocates to ban the Juul vaping products, but the officials stated they need sufficient time and evidence to proceed.

Companies manufacturing e-cigarettes need to provide precise data about the benefits of the products to public health how they will help to reduce or quit smoking among heavy smokers and prevent smoking addiction among the underage. The companies might be able to survive in the market if they manage to provide such data.

Attorneys for the plaintiffs and families of the affected people are outraged because of the delay in the decision. They even showed concern about the growing addiction problem among teens.

E-cigarettes were introduced in the U.S. market a decade ago to provide a less harmful alternative to smokers. But as per the industry experts, the products did not serve the purpose and fueled nicotine addiction among the teens and adults who smoke.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Teen E-cigarette Use Hits 10-Year Low

Categories: E-Cigarette: JUUL

Federal officials report a significant decline in teen vaping rates in the U.S., with about half a million fewer middle and high school…

Baltimore, Walgreens Reach Opioid Settlement Totaling $402.5m

Categories: Opioids

The City of Baltimore has reached a settlement with Walgreens over its involvement in the opioid crisis, marking the…

Drug Distributors Reach $300M Opioid Settlement

Categories: Opioids

The three largest U.S. drug distributors—McKesson Corp, Cencora Inc, and Cardinal Health Inc—have agreed to pay $300 million to settle claims by health insurers and benefit plans over their role in fueling the U.S.…

Labor Day Litigation Bonanza!     
Free Trials + 15% Discount!